Advanced glycation end products and sorbitol in blood from differently compensated diabetic dogs

Research in Veterinary Science

Volumn 84, Issue 3, 2008, Pages 341-346

  Comazzi, S ^a   Bertazzolo, W ^b   Bonfanti, U ^c   Spagnolo, V ^a   Sartorelli, P ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Pronto Soccorso Veterinario   (Italy)

^c Clinica Veterinaria Gran Sasso   (Italy)

Author keywords

AGE products; Blood; Diabetes mellitus; Dog; Sorbitol

Indexed keywords

ADVANCED GLYCATION END PRODUCT; POLYOL; SORBITOL;

ANIMAL EXPERIMENT; ANIMAL HEALTH; ARTICLE; BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DOG; ERYTHROCYTE LEVEL; KETONURIA; NONHUMAN; PROGNOSIS; PROTEIN GLYCOSYLATION;

ANIMALS; DIABETES MELLITUS; DOG DISEASES; DOGS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPERGLYCEMIA; MALE; REPRODUCIBILITY OF RESULTS; SORBITOL;

ANIMALIA; CANIS FAMILIARIS;

EID: 41749118935     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2007.05.013     Document Type: Article

References (17)

1. Basher A.W.P., and Roberts S.M. Ocular manifestations of diabetes mellitus: diabetic cataracts in dogs. Veterinary Clinics of North American: Small Animal Practice 25 3 (1995) 661-675
2. Christopher M.M. Hematologic complications of diabetes mellitus. Veterinary Clinics of North American: Small Animal Practice 25 3 (1995) 625-636
3. Comazzi S., Spagnolo V., and Giordano A. "In vitro" effect of hyperglycemia and ketoacidosis on some aspects of erythrocytes metabolism in dog. Veterinary Clinical Pathology 31 4 (2002) 198
4. Comazzi S., Paltrinieri S., Spagnolo V., and Sartorelli P. Some aspects of erythrocyte metabolism in insulin-treated diabetic dogs. Research in Veterinary Science 72 1 (2002) 23-27
5. Gillery P. Advanced glycation end products (AGEs), free radicals and diabetes. Journal de la Societe de Biologie 195 4 (2001) 387-390
6. Hayashi R., Hayakawa N., Makino M., Nagata M., Kakizawa H., Uchimura K., Hamada M., Aono T., Fujita T., Shinohara R., Nagasaka A., and Itoh M. Changes in erythrocyte sorbitol concentrations using an improved assay system in patients with diabetic complications and treated with aldose reductase inhibitor. Diabetes Care 21 4 (1998) 672-673
7. Jensen A.L. Various protein and albumin corrections of the serum fructosamine concentration in the diagnosis of canine diabetes mellitus. Veterinary Research Communication 17 (1993) 13-23
8. Jensen A.L. Glycated blood proteins in canine diabetes mellitus. Veterinary Record 137 (1995) 401-405
9. Miyamoto S. Molecular modeling and structure-based drug discovery studies of aldose reductase inhibitors. Chem-Bio Informatic Journal 2 3 (2002) 74-85
10. Münch G., Keis R., Webels A., Riederer P., Bahner U., Heidland A., Niwa T., Horst-dieter L., and Chinzel R. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. European Journal of Clinical Chemistry and Clinical Biochemistry 35 9 (1997) 669-677
11. Reusch C.E., Liehs M.R., Hoyer M., and Vochezer R. Fructosamine. A new parameter for diagnosis and metabolic control in diabetc dogs and cats. Journal of Veterinary Internal Medicine 7 3 (1993) 177-182
12. Richter M., Guscetti F., and Spiess B. Aldose reductase activity and glucose-related opacities in incubated lenses from dogs and cats. American Journal of Veterinary Research 63 11 (2002) 1591-1597
13. Shinohara R., Ohta Y., Yamauchi M., and Ishiguro I. Improved enzymatic sorbitol assay in human blood. Clinica Chimica Acta 273 (1998) 171-184
14. Solberg H.E. Establishment and use of reference values. In: Burtis C.A., and Ashwood E.R. (Eds). Tiezt textbook of clinical chemistry. third ed. (1994), W.B. Saunders, London 454-484
15. Stitt A.W. Advanced glycation: an important pathological event in diabetic and age related ocular disease. British Journal of Ophthalmology 85 (2001) 746-753
16. Wang H., Zhang Z., Wen R., and Chen J. Experimental and clinical studies on the reduction of erythrocyte sorbitol-glucose ratios by ascorbic acid in diabetes mellitus. Diabetes Research and Clinical Practice 28 (1995) 1-8
17. Yanagisawa K., Makita Z., Shiroshita K., Ueda T., Fusegawa T., Kuwajima S., Takeuchi M., and Koike T. Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients. Metabolism 47 11 (1998) 1348-1353